Research note from Redeye
February 8, 2018
(Non-regulatory)
Link to Redeye’s research note commenting Pledpharma’s press release from February 8.
News room
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment
February 8, 2018
(Non-regulatory)
Link to Redeye’s research note commenting Pledpharma’s press release from February 8.
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: [email protected]
